← Leaderboards
Miodrag G Radulovacki
University Of Illinois At Chicago
$3,188,150
Attributed
$6,361,356
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$11,220,129 · 4
By mechanism
UM1$9,717,546 · 3
R01$1,502,583 · 1
Top collaborators
- Phyllis C Zee9 shared
- David W. Carley6 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- David W. Carley$5,671,894
- Stephen Reilly$5,538,888
- Anne M Fink$1,049,465
- Donovan B Yeates$2,763,658
- Thomas R Stratford$1,104,763
Others in their field
Top investigators on “Apnea”
- Susan S Redline · Brigham And Women'S Hospital$67,685,247
- Jane Wilkinson · Broad Institute, Inc.$38,181,500
- Allan Ian Pack · University Of Pennsylvania$30,235,234
- Nanduri R Prabhakar · Case Western Reserve University$28,615,852
- Jack L. Feldman · University Of California Los Angeles$27,410,312
- Devin L Brown · University Of Michigan At Ann Arbor$24,562,868
Research focus
ApneaAnimalsReflex ActionBaseConsciousBreathingInstrumentPathway InteractionsSleep Apnea SyndromesSleepClinical TrialsAlertnessClinical ResearchCognitiveDiabetes MellitusIndexingDoseCardiovascular SystemClinically SignificantHuman DataCessation Of LifeBehavioral SymptomsBrainHypertension
Grant awards (13)
Cannabimimetic treatment of obstructive sleep apnea: A proof of concept trial$1,881,836
UM1 · FY2014 · HL
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial$1,749,525
UM1 · FY2014 · HL
Basic Ancillary Study$132,311
UM1 · FY2014 · HL · contact PI
Cannabimimetic treatment of obstructive sleep apnea: A proof of concept trial$1,981,987
UM1 · FY2013 · HL
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial$1,853,456
UM1 · FY2013 · HL
Basic Ancillary Study$128,531
UM1 · FY2013 · HL · contact PI
Cannabimimetic treatment of obstructive sleep apnea: A proof of concept trial$994,950
UM1 · FY2012 · HL
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial$859,939
UM1 · FY2012 · HL
Basic Ancillary Study$135,011
UM1 · FY2012 · HL · contact PI
Intertrigeminal region control of apnea$369,482
R01 · FY2007 · HL · contact PI
Intertrigeminal region control of apnea$380,518
R01 · FY2006 · HL · contact PI
Intertrigeminal region control of apnea$376,283
R01 · FY2005 · HL
Intertrigeminal region control of apnea$376,300
R01 · FY2004 · HL